Alterity Therapeutics Limited (ATHE)
$3.12+1.63%Close
SELLCRISIS · day 22
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $53M
- Beta
- -0.03
- P/E (TTM)
- -3.71
- Short % float
- 0.22%
- Days to cover
- 2.2
- SI change
- +1.7%
- 1W
- -9.57%
- 1M
- -24.09%
- vs SPY 1W
- -10.73%
- vs SPY 1M
- -27.08%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATHE?
- LOPJLB’s latest quantitative signal on Alterity Therapeutics Limited (ATHE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ATHE in?
- Alterity Therapeutics Limited (ATHE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Alterity Therapeutics Limited (ATHE) do?
- Alterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for various neurological disorders, such as Alzheimer's, Huntington's, and Parkinson's diseases. Its prominent experimental therapy, ATH434, has completed Phase I clinical trials targeting Parkinson's disease. The company is also advancing PBT2, a compound that …